Catheter-based alternative treatment for early-stage lung cancer with a high-risk for morbidity
- PMID: 30026973
- PMCID: PMC6035930
- DOI: 10.21037/jtd.2018.03.151
Catheter-based alternative treatment for early-stage lung cancer with a high-risk for morbidity
Abstract
The mainstream treatment modality for early stage non-small cell lung cancer (NSCLC) is surgery; however, many patients are deemed inoperable and warrant alternative therapeutic options. Several minimally invasive catheter-based therapies are emerging as viable alternatives. In this review, we evaluate the outcomes from radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation (CRA) and photodynamic therapy (PDT) for early-stage lung cancer. Novel technical developments have allowed for endobronchial thermal ablation to be conducted in a hybrid theatre setting, which may optimize treatment outcomes and minimise treatment-related complications.
Keywords: Thermal therapy; alternative treatment; early stage; non-small cell lung cancer (NSCLC).
Conflict of interest statement
Conflicts of Interest: CS Ng has an electromagnetic navigational bronchoscopy system SuperDimension Version 7 on loan from Medtronic. ZR Zhao and RW Lau have no conflicts of interest to declare.
Figures

References
Publication types
LinkOut - more resources
Full Text Sources